Metabiomed메타바이오메드
059210 · KOSDAQ · ₩059210 · 메타바이오메드
₩3,635▲ ₩10 (0.28%)End-of-day · Oct 30, 2026 · End-of-day prices.
Filings
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 2, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Sep 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Aug 25, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 16, 2026Open on DART
- Adjustment of Conversion Price전환가액의조정Jul 13, 2026Open on DART
- Report on Treasury Stock Acquisition Results자기주식취득결과보고서Jul 3, 2026Open on DART
- Amended: Cash dividend decision[기재정정]현금ㆍ현물배당결정Jun 30, 2026Open on DART
- Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)Jun 29, 2026Open on DART
- Cash dividend decision현금ㆍ현물배당결정Jun 25, 2026Open on DART
- Decision on Shareholder Register Closure (Record Date) for Interim (Quarterly) Dividend중간(분기)배당을위한주주명부폐쇄(기준일)결정Jun 15, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Jun 12, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Jun 12, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 12, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 12, 2026Open on DART
- Acquisition of Convertible Bonds (Including Overseas Convertible Bonds) After Issuance and Before Maturity전환사채(해외전환사채포함)발행후만기전사채취득Jun 11, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jun 4, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서May 22, 2026Open on DART
- Amended: Quarterly report (Mar 2026)[기재정정]분기보고서 (2026.03)May 15, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Amended: Share buyback decision[기재정정]주요사항보고서(자기주식취득결정)May 14, 2026Open on DART
- Share buyback decision주요사항보고서(자기주식취득결정)May 14, 2026Open on DART
- Results of Extraordinary Shareholders' Meeting임시주주총회결과May 13, 2026Open on DART
- Amended: Insider shareholding report[기재정정]임원ㆍ주요주주특정증권등소유상황보고서Apr 27, 2026Open on DART
- Amended: Insider shareholding report[기재정정]임원ㆍ주요주주특정증권등소유상황보고서Apr 27, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 23, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 23, 2026Open on DART
- Amended: Shareholders' meeting called[기재정정]주주총회소집결의Apr 22, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Apr 22, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Apr 22, 2026Open on DART
- Amended: Shareholders' meeting called[기재정정]주주총회소집결의Apr 17, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Apr 6, 2026Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Apr 6, 2026Open on DART
- Corporate value-up plan기업가치제고계획(자율공시)Mar 31, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 31, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 31, 2026Open on DART
- Amended: Cash dividend decision[기재정정]현금ㆍ현물배당결정Mar 24, 2026Open on DART
- Audit report submitted감사보고서제출Mar 23, 2026Open on DART
- Added attachment: Annual report (Dec 2025)[첨부추가]사업보고서 (2025.12)Mar 23, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 17, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 17, 2026Open on DART
- Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Mar 16, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 16, 2026Open on DART
- Cash dividend decision현금ㆍ현물배당결정Mar 16, 2026Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Mar 16, 2026Open on DART
- Share cancellation decision주식소각결정Feb 20, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 3, 2026Open on DART
- Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Feb 3, 2026Open on DART
Titles in Korean until English translations are added.
Also known as: Metabiomed / 메타바이오메드 / 059210 / KRX:059210
Source: KRX statistical information